Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Some of the biggest psychedelic news this week include the Colorado Senate passing a bill to regulate psychedelics.
In a tight race that came down the wire, Colorado voters approve Measure 122 to decriminalize small amounts of psychedelic drugs
This November, Colorado voters have the chance to decriminalize psychedelic plant medicines for personal and therapeutic use
San Francisco becomes the latest city to decriminalize entheogenic plants in another win for Decriminalize Nature
The company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
Seattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law enforcement priorities.
Explore how the Mazatecs, the Shipibo People, Yanomami People, and Africans practicing the Bwiti religion continue to use various entheogens to this day.
“Decriminalization of entheogenic substances makes sense,” says Senator Jeff Irwin. “Let’s stop wasting time and money making more victims of the War on Drugs.”
The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.